Todd KruegerChief Executive Officer and President at AOBiome
Todd Krueger, AOBiome’s President and CEO, has over 20 years of experience in healthcare strategy, business development, operations and finance. Prior to joining AOBiome in 2015, Mr. Krueger led commercial efforts for the genomics platform at the Broad Institute and held senior positions at Claritas Genomics and Life Technologies. He has been involved in the founding of several biotech startups, including Gynesonics, Nodality, and Anestis Therapeutics. In 1999 he co-founded Fluidigm Corporation (NASDAQ:FLDM), a biological research equipment company, where he served as CFO and Vice President of Business Development. He started his career as a consultant for Bain and Company, a management consulting firm to Fortune 500 clients. He currently serves as a director of General Automation Laboratory Technologies, Inc. (GALT), a microbiome tools company. Mr. Krueger graduated Highest Distinction from Northwestern University with a degree in Economics and earned his MBA from the Kellogg School of Management.